Should I Buy CSX? CSX 2026 Analysis

Should You Buy CSX Corp (CSX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Buy

Latest Price

40.610

1 Day change

1.86%

52 Week Range

40.710

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Buy now for a momentum/swing-style entry: trend is bullish (SMA_5 > SMA_20 > SMA_200 + expanding positive MACD) and options positioning is risk-on.
Near-term upside looks limited but still favorable: price is already above R1 (39.423) and the next technical magnet is R2 (~40.436).
Not a value-style buy at this level: hedge funds have been selling heavily and several analysts trimmed targets after a softer Q4/2026 outlook, implying the stock is closer to “fair” than “cheap.”

Intellectia Proprietary Trading Signals

AI Stock Picker: No signal on given stock today.
SwingMax: Entry signal was on 2026-01-14; stock is +10.71% since then. This is not an early entry anymore, but the trend remains constructive enough to justify buying now if you want immediate exposure.

Technical Analysis

Trend: Bullish structure with stacked moving averages (SMA_5 > SMA_20 > SMA_200) confirming an established uptrend.
Momentum: MACD histogram +0.343 and expanding → upside momentum is strengthening.
Overbought: RSI_6 at 85.29 indicates stretched conditions (chasing risk is higher), but it also confirms strong demand.
Levels: Pivot 37.782 (key near-term support). Resistance: R1 39.423 already reclaimed; next resistance R2 40.436.
Pattern-based forward bias (similar candlesticks): ~+0.3% next day, -1.55% next week, +4.63% next month → suggests choppy near-term but constructive 1-month drift.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Sentiment: Put/call ratios are low (OI PCR 0.45; Volume PCR 0.3) → positioning skews bullish.
Activity: Today’s option volume is elevated vs 30-day average (7.34x), signaling unusually strong attention/participation.
Volatility: 30D IV 27.06 vs historical vol 20.94 → options pricing implies higher-than-realized uncertainty; IV percentile ~54 (middle-of-the-road), not extreme.
OI/flow mix: Calls dominate open interest (174,013 calls vs 78,495 puts), consistent with optimistic positioning.

Technical Summary

Sell

Buy

Positive Catalysts

- No negative news headlines in the last week to disrupt momentum.

Neutral/Negative Catalysts

- Hedge funds are selling aggressively (selling amount up 6358.05% QoQ) → institutional flow headwind.
- Overbought RSI (85+) → increases odds of a short-term cooling period.
- Macro/demand caution cited by analysts following Q4 results; guidance implied softness vs prior expectations.
- Some Wall Street views imply limited upside at current price (e.g., “fully valued” commentary).

Financial Performance

Latest quarter: 2025/Q4.
Revenue: $3.508B, -0.88% YoY (top-line slightly contracting).
Net income: $720M, -1.77% YoY (profit dollars down modestly).
EPS: $0.39, +2.63% YoY (per-share growth despite weaker revenue, likely helped by cost actions/buybacks).
Gross margin: 58.01%, down 1.96% YoY (margin pressure remains a watch item).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend (Jan 23, 2026 cluster): multiple firms trimmed/adjusted price targets post-Q4; ratings mostly maintained (Buy/Outperform/Neutral/Market Perform).
Targets are now tightly clustered around the current price range (roughly mid-30s to low-40s), implying more “range-bound” expectations near term.
Bull case (Wall St pros): margin improvement potential into 2026, cost/ROIC focus under new CEO, upside if demand recovers.
Bear/base case (Wall St cons): cautious macro/demand outlook and a Q4 EPS miss; some analysts see the stock as fully valued around current levels.
Influential/congress trading: No recent congress trading data available; insiders are neutral with no significant last-month trend.

17 Analyst Rating

Wall Street analysts forecast CSX stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CSX is 39.5 USD with a low forecast of 30 USD and a high forecast of 45 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

13 Buy

4 Hold

0 Sell

Strong Buy

Current: 39.870

Low

Averages

39.5

High

Current: 39.870

Low

Averages

39.5

High

Evercore ISI

Outperform

downgrade

$41 -> $40

AI Analysis

2026-01-23

Reason

Evercore ISI

Price Target

$41 -> $40

AI Analysis

2026-01-23

downgrade

Outperform

Reason

Evercore ISI lowered the firm's price target on CSX to $40 from $41 and keeps an Outperform rating on the shares. Q4 EPS missed expectations, but margin prospects for 2026 "provide a silver lining" as the company's outlook suggests potential margin improvements that could outweigh shortfalls in revenue and earnings, the analyst tells investors.

Susquehanna

Neutral

maintain

$38 -> $39

2026-01-23

Reason

Susquehanna

Price Target

$38 -> $39

2026-01-23

maintain

Neutral

Reason

Susquehanna raised the firm's price target on CSX to $39 from $38 and keeps a Neutral rating on the shares. The firm updated its model following Q4 results and noted under new CEO Steve Angel, CSX is focused on the right things to drive shareholder value mid-term; drivingcosts lower and ROIC and cash flows higher, and that can only improve potential long-term merger outcomes.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CSX

Unlock Now

CSX Should I Buy

CSX Should I Buy

Should You Buy CSX Corp (CSX) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch